Project Details
Description
Older patients with type 2 diabetes mellitus (T2D) have an increased risk of hypoglycaemic episodes when using sulphonylureas or insulin. In the Netherlands, guidelines exist for reducing glucose-lowering medication in older patients. However, evidence is lacking that a medication reduction in older patients can be safely pursued. Here, we will examine if promoting the deprescribing of insulin/sulphonylureas with a deprescribing programme (DPP) in general practice affects T2D-complications in older overtreated patients.
Short title | OMED2-study |
---|---|
Acronym | OMED2-study |
Status | Active |
Effective start/end date | 1/03/2023 → 1/06/2026 |
Keywords
- Type 2 diabetes
- elderly
- hypoglycamia
- SU
- insulin
- deprescribing
- medication